
Evidence analysis
Analysis of the impact of naturally-acquired immunity on <i>Shigella</i> vaccine performance to inform clinical trials: A simulation-based modeling study
Evidence Dossier: Shigella Vaccine Trials and Human Rights Implications What is established Shigella is a leading bacterial cause of diarrheal disease worldwide, disproportionately affecting children in low-resource settings. Effective vaccination against Shigella offers potential to reduce the burden…
Read →
Evidence analysis
Who should take GLP-1s?
Who Should Take GLP-1s? Evidence and Discussion from Harvard Experts GLP-1 receptor agonists, drugs initially developed to treat Type 2 diabetes, have rapidly gained attention for their role in weight management. As nearly one in eight American adults…
Read →
Evidence analysis
Selective nostalgia
What is established In the mid-1970s, Harvard curator Barbara “Bobbie” Norfleet undertook a cross-country road trip to collect a large archive of photographic images of American life, focusing on the work of professional community photographers rather than classical…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Vyvgart, efgartigimod alfa, Date of authorisation: 10/08/2022, Revision: 11, Status: Authorised
What is established Vyvgart (efgartigimod alfa) is an authorised medicine in the European Union for adults with two rare neuromuscular autoimmune disorders: generalised myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP). Both diseases involve an abnormal immune…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Date of authorisation: 20/10/1995, Revision: 28, Status: Authorised
What is established GONAL-f, containing the active substance follitropin alfa, is a medicine authorised in the European Union since 1995. It is manufactured by Merck Serono Europe Ltd and is used primarily in fertility treatments. Follitropin alfa is…
Read →
Evidence analysis
PSUSA/00000078/202601
Evidence Dossier: Periodic Safety Update on Alendronate – European Medicines Agency (EMA) Report, October 2026 This dossier presents an analysis of the October 2026 Periodic Safety Update Report Single Assessment (PSUSA) concerning alendronate, as published by the European…
Read →
Evidence analysis
Burkina Faso Restores Death Penalty
What is established Burkina Faso’s unelected parliament has passed a new penal code reinstating the death penalty for crimes including high treason, terrorism, espionage, parricide, and the importation of expired or prohibited products. This legislative change reverses a…
Read →
Evidence analysis
Kremlin payment firm A7 has been pumping billions in ‘untraceable’ cash into global financial system
Evidence Dossier: Kremlin Payment Firm A7 and Its Role in the Global Financial System What is established An investigation by the International Consortium of Investigative Journalists (ICIJ), based on leaked internal documents and expert interviews, shows that A7,…
Read →
Evidence analysis
New US law requires dating apps to include warnings on romance scams
What is established In October 2026, a new U.S. federal law, the Romance Scam Prevention Act, was signed by President Donald Trump. This bipartisan law requires online dating platforms to notify users if they have been communicating with…
Read →
Evidence analysis
In a Vienna Bakery, Fresh Pastries and a Backdoor for Serbian Votes
Evidence Dossier: Unofficial Serbian Diaspora Voting in Vienna What is established A bakery and an adjoining Serbian association in Vienna, Austria, have functioned as informal locations where Serbian diaspora voters register for elections. This group is associated with…
Read →